Linkage Biosciences is a molecular diagnostics company developing products that will dramatically improve and expedite complex genetic testing. Our initial focus is on diagnostic products for solid organ and hematopoietic stem cell transplantation where our proprietary technology will have an immediate impact. We have assembled an outstanding management team and scientific advisory board who are well known experts in their respective fields. Please stay tuned for further announcements.
News
Linkage Biosciences Secures Series A Financing
SAN FRANCISCO, California FEBRUARY 4, 2009 Linkage Biosciences Inc., a developer of molecular diagnostic products designed to streamline complex genetic testing, has completed a Series A financing led by Greenhouse Capital Partners and James R. Fisher, managing member of Fisher Capital Corp. II LLC, a firm that works exclusively with private equity firm Kohlberg Kravis Roberts & Co..Read more…